“PRIMARYS” study Investigators observed clinically relevant results in an investigational Phase III study with Somatuline® Autogel® 120 mg in patients with acromegaly

Understanding the true impact of living with FOP

Ipsen Announces Decision to Permanently Discontinue Distribution of NutropinAq® (somatropin) cartridges

Applications now open for the 2023 Golden Ticket Competition

Offering support to those impacted in Turkey & Syria